Intrepid Financial Planning Group LLC Actinium Pharmaceuticals, Inc. Transaction History
Intrepid Financial Planning Group LLC
- $224 Million
- Q2 2025
A detailed history of Intrepid Financial Planning Group LLC transactions in Actinium Pharmaceuticals, Inc. stock. As of the latest transaction made, Intrepid Financial Planning Group LLC holds 12,500 shares of ATNM stock, worth $18,875. This represents 0.01% of its overall portfolio holdings.
Number of Shares
12,500
Previous 14,500
13.79%
Holding current value
$18,875
Previous $23,000
26.09%
% of portfolio
0.01%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding ATNM
# of Institutions
64Shares Held
7.01MCall Options Held
39.2KPut Options Held
0-
Black Rock Inc. New York, NY1.88MShares$2.83 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.37MShares$2.07 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny663KShares$1 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA492KShares$742,8330.0% of portfolio
-
Geode Capital Management, LLC Boston, MA330KShares$497,8300.0% of portfolio
About Actinium Pharmaceuticals, Inc.
- Ticker ATNM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,184,700
- Market Cap $38M
- Description
- Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly re...